$1.69
0.063.68%
Last update: Nov 6, 7:46 PM
Tenax Therapeutics Inc (TENX) Stock Price, Quote, News & History
TENXNASDAQ
Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints while showing subgroup benefits.
You can purchase shares of Tenax Therapeutics (NASDAQ:TENX) through any online brokerage.
Other companies in Tenax Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Tenax Therapeutics has a consensus price target of $22.50.
The stock price for Tenax Therapeutics (NASDAQ: TENX) is $1.71 last updated November 6, 2026 at 7:46 PM EST.
There are no upcoming dividends for Tenax Therapeutics.
Tenax Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Tenax Therapeutics.
Tenax Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on...
